ArticleJournal for immunotherapy of cancer2026

Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma.

Robin Reschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.